Novavax Inc. shares were volatile in the extended session Wednesday after the biotech drug maker said initial data showed its COVID-19 vaccine booster showed immune responses against the omicron variant.
Novavax Inc. shares were volatile in the extended session Wednesday after the biotech drug maker said initial data showed its COVID-19 vaccine booster showed immune responses against the omicron variant.
Fintedex delivers real-time news about the financial industry: feature stories, industry developments, opinions plus the latest on people and trends.
© 2021 Fintedex.